Unknown

Dataset Information

Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical Trial.


ABSTRACT:

Importance

Induction chemotherapy followed by high-dose therapy with autologous stem cell transplant and subsequent antidisialoganglioside antibody immunotherapy is standard of care for patients with high-risk neuroblastoma, but survival rate among these patients remains low.

Objective

To determine if tandem autologous transplant improves event-free survival (EFS) compared with single transplant.

Design, setting, and participants

Patients were enrolled in this randomized clinical trial from November 2007 to February 2012 at 142 Children's Oncology Group centers in the United States, Canada, Switzerland, Australia, and New Zealand. A total of 652 eligible patients aged 30 years or younger with protocol-defined high-risk neuroblastoma were enrolled and 355 were randomiz

SUBMITTER: Park JR 

PROVIDER: S-EPMC6714031 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature